Advance Health: The acceleration of digital health in the COVID-19 world

Advance Health recently convened a panel of local and international experts to discuss the acceleration of digital health in the COVID-19 world and the role of digital technology in the healthcare sector.

The panel discussed various aspects of digital health including data and systems integration, advancing telemedicine, data privacy and the importance of regulatory oversight.


  • Dr Mohammad Al Redha, Director, Project Management Office, Health Informatics & Smart Health, Dubai Health Authority, UAE
  • Dr Louise Schaper, CEO, Australasian Institute of Digital Health, Australia 
  • Alex Butler, Co-Founder, Foundry3, UK
  • Christine Arakelian, Founder and CEO, Global Healthcare Integrators, USA
  • Marwan Abdulaziz Janahi, Managing Director, Dubai Science Park, UAE

Advance Health: Mental Health Webinar

Advance Health convened an expert panel of leading mental health experts to share knowledge and discuss effective coping mechanisms that promote physical and emotional wellbeing during these unprecedented times.

The panel discussed how we can navigate the ‘new normal’ of working from home, staying indoors and striking a work-life balance that promotes our physical and emotional well-being. This included tips to boost positivity, happiness and productivity during these unprecedented times.


  • Dr Adil Sajwani, Family Medicine Specialist Doctor, Ministry of Health and Prevention, Member of COVID-19 National Awareness Team
  • Dr Muhammad Tahir, Chairman of the Board at American Wellness Center DHCC, Founding Member of the Emirates Society for Child and Adolescent Mental Health
  • Dr Sarah Rasmi, Psychologist and Managing Director, Thrive Wellbeing Centert
  • Maher El Hassan, Vice President & General Manager, Becton Dickinson MENA & Saudi
  • Moderator: Marwan Abdulaziz Janahi, Managing Director, Dubai Science Park

Advance Health: Coronavirus Webinar – A UAE perspective on the facts, myths and challenges

Advance Health convened a multidisciplinary expert panel this week to discuss the facts, myths, and challenges surrounding COVID-19.

The panel of UAE experts shared valuable insights and opinions on the day-to-day challenges and the projected impact of the novel coronavirus (COVID-19) pandemic. The panel delves into some of the key facts, offer guidance on how to prevent transmission of the disease, and discuss what the future may hold for vaccines and therapies.


  • Dr Fatma Bin Shabib, Head of Health Policy Development, Dubai Health Authority
  • Dr Wael Elamin, Consultant Clinical Microbiologist and Infection Control Doctor, King’s College Hospital Dubai
  • Dr Immanuel Azaad Moonesar, Associate Professor of Health Administration and Policy, Mohammed Bin Rashid School of Government
  • Moderator: Marwan Abdulaziz Janahi, Managing Director, Dubai Science Park

Role of healthcare technology in fighting diabetes

Dubai Science Park (DSP), a science and healthcare-focused business community, hosted the 10th edition of its Advance Health forum to highlight how technology is transforming diabetes treatment and prevention in the UAE.

The relentless rise of disruptive technology is transforming healthcare systems around world and the role of health-tech in diabetes diagnosis continues to surge in proportion to this growth.

Organised in partnership with Connect Communications and Synapse Medical Services, Advance Health took place on January 29 at Arab Health.

It was chaired by Marwan Abdulaziz Janahi, Managing Director of Dubai Science Park and Chairing Member of the Pharmaceuticals and Medical Equipment Taskforce of the Dubai Industrial Strategy 2030.

Speaking at the session, Janahi said: “Diabetes is on the rise and reducing the number of patients diagnosed each year is a priority not just in the UAE but globally. Dubai Science Park is proud to support innovative business partners who are using new technologies to diagnose and treat the disease. With modern offices, laboratories and warehouses, our ecosystem has advanced infrastructure and a business-friendly environment to help healthcare companies from multinational corporations to SMEs and startups contribute significantly to reducing diabetes prevalence.”

Janahi was joined at the panel discussion by Fatheya Al Awadi, Head of Endocrinology at Dubai Hospital, Scott Cunningham, Chief Technical Officer at MyWay Digital Health, Dr Nairah Rasul-Syed, Medical Director & Consultant at Virtual Home Healthcare Services, and Ben McGough, Digital Workstream Lead at the NHS Diabetes Programme.

According to the latest data from the International Diabetes Federation, more than 460 million people – one in 11 adults – suffer from diabetes. It is estimated that 19 per cent of the UAE population has diabetes, and if the current trend continues, 32 per cent of adults aged between 20 and 79 may have diabetes or prediabetes by the next decade in the country.

The World Health Organisation (WHO) ranked diabetes as the seventh-leading cause of death worldwide in 2016. The problem is particularly severe in the UAE – one of the world’s top 10 countries for diabetes prevalence – and the wider Middle East. The findings come from a study by three researchers from the College of Medicine and Health Sciences of the United Arab Emirates University in Al Ain, published in the peer-reviewed medical journal BMJ Open.

Dubai Science Park hosted Advance Health as part of its ongoing commitment to promoting discussion, encouraging networking, supporting growth in science and technology, and helping its business partners contribute to UAE’s ongoing economic diversification.

Ninth Edition of Advance Health Explores Transformative Powers of Next-generation Sequencing: Dubai presented as a hub for innovative scientific research

Dubai Science Park (DSP), a science- and healthcare-focused business community, convened key industry stakeholders at the ninth edition of its Advance Health forum that highlighted the latest trends in next-generation sequencing (NGS).

Organised in partnership with Synapse Medical and Connect Communications, the event took place on 21 November under the theme ‘Next Generation Sequencing – Empowering Clinical Practice’.

NGS, also known as high-throughput sequencing, is the catch-all term used to describe a variety of modern technologies that enable faster and more economical DNA sequencing. For example, using NGS, an entire human genome can be sequenced within a single day. Additionally, the advanced functionality is visible in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a subset of NGS. New research aims to deploy genome editing as a solution to bacterial infections since an alarming number of bacteria are now resistant to one or more antibiotics.

A panel discussion offered insights from a research, clinical, pharmaceutical and technological perspective. Panellists included Habiba Al Safar, Director of Biotechnology Center, Khalifa University, Ahmad Abou Tayoun, Director of Al Jalila Genomics Center, Al Jalila Children’s Specialty Hospital, Abdullah Al-Rahho, Channel Sales Lead, Thermo Fisher Scientific, Marwan Abdulaziz Janahi, Managing Director of DSP and Chairing Member of the Pharmaceuticals and Medical Equipment Taskforce of the Dubai Industrial Strategy 2030.

Marwan Abdulaziz Janahi said: “We are committed to stimulating dialogue for the benefit of our business partners and the wider science community. Through embracing the imminent universal availability of NGS, we can fast-track the positioning of Dubai as a centre of life sciences research, clinical and pharmaceutical discovery, and bioscience innovation.”

He added: “As one of the most rapidly advancing technologies in history, NGS creates a wealth of vital transformative opportunities to expand our understanding of bio medicine, change the face of clinical care and improve human health. It also opens broad prospects for innovation and economic growth. In this context, it is safe to say that precision medicine is the next global space race.”

Habiba Al Safar said: “Our health is determined by our inherent differences combined with our lifestyles and environment. Today, with the enormous development in genomics research, we are moving away from the traditional approach of one-size-fits-all medical approach to more personalised treatments in healthcare based on individual genetic make-up. Understanding the relationship between your genome and lifestyle is an important first step and key to personalizing your health care.

Al Safar highlighted that NGS will bring in newer diagnostic capabilities and make advanced genetic testing more accessible in the UAE to ensure a longer, happier and healthier life for all its citizens. “Needless to say, a healthier population is a productive one, that also makes an important contribution to our country’s economic progress,” she added.

Dubai continues to play an important role in driving the local biotech industry forward. The emirate is expected to attract US$2.5 billion in investments in the pharmaceutical sector over the next five years as it ramps up efforts to motivate international organisations to open factories here as part of the Dubai Industrial Strategy 2030. The introduction of new biotechnological products that cater to healthcare entities involved in diagnosis, prognosis and biopharmaceutical development is estimated to give a significant boost to the global market, with the Asia Pacific market poised for the fastest growth.

Dubai Science Park hosts the Advance Health series with the aim of promoting information sharing, encouraging networking opportunities and improving patient outcomes in the UAE. DSP supports the biotech sector through providing a business-friendly environment to attract leaders in the field.